Menopausal Hormone Therapy and Risk of Endometrial Cancer: A Systematic Review
Background: Menopausal hormone therapy (MHT) is an appropriate treatment for women with the climacteric syndrome. The estrogen component of MHT effectively alleviates climacteric symptoms but also stimulates the endometrium and thus may increase the risk of endometrial cancer (EC). Materials and Met...
Main Authors: | Clemens B. Tempfer, Ziad Hilal, Peter Kern, Ingolf Juhasz-Boess, Günther A. Rezniczek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2195 |
Similar Items
-
Progestogens in menopausal hormone therapy
by: Małgorzata Bińkowska, et al.
Published: (2015-06-01) -
Effects of menopausal hormone therapy on ambulatory blood pressure and arterial stiffness in postmenopausal Korean women with grade 1 hypertension: a randomized, placebo-controlled trial
by: Byung-Koo Yoon, et al.
Published: (2021-09-01) -
Hormone replacement therapy and effects on mood
by: Björn, Inger
Published: (2003) -
Menopausal hormone therapy (MHT): the current thinking, the benefits, and the risks
by: M. Wattegama, et al.
Published: (2021-04-01) -
50 years of hormonal contraception – time to find out, what it does to our brain
by: Belinda ePletzer, et al.
Published: (2014-08-01)